Ad
APVO Short Information Aptevo Therapeutics Inc.
home / stock / apvo / apvo short
Short Information | Aptevo Therapeutics Inc. (NASDAQ:APVO)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 742,064 |
| Total Actual Volume | 3,353,641 |
| Short Trends | |
|---|---|
| Cover Days | 20 |
| Short Days | 0 |
| No Change Days | 0 |
| Averages | |
|---|---|
| Average Short Volume | 37,103 |
| Average Short Percentage | 20.34% |
Is there a APVO Short Squeeze or Breakout about to happen?
See the APVO Short Analysis for free Sign up or Login
Powered by Squeeze Report
APVO Twenty Trading Day's Volume to Short Volume Chart
APVO Twenty Trading Day Price Chart
APVO Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 01-14-2025 | $4.74 | $4.55 | $4.74 | $4.5 | 16,712 | 2,060 | 12.33% |
| 01-13-2025 | $4.72 | $4.55 | $4.75 | $4.3 | 67,999 | 20,688 | 30.42% |
| 01-10-2025 | $4.93 | $4.79 | $5.19 | $4.66 | 65,745 | 13,003 | 19.78% |
| 01-08-2025 | $5.14 | $4.98 | $5.16 | $4.6562 | 37,136 | 9,276 | 24.98% |
| 01-07-2025 | $5.15 | $5.17 | $5.49 | $5.0191 | 119,611 | 23,265 | 19.45% |
| 01-06-2025 | $4.73 | $5.1 | $5.3 | $4.58 | 172,580 | 36,299 | 21.03% |
| 01-03-2025 | $4.85 | $4.58 | $4.905 | $4.4 | 66,356 | 13,195 | 19.89% |
| 01-02-2025 | $4.42 | $4.57 | $4.66 | $4.37 | 53,620 | 15,932 | 29.71% |
| 12-31-2024 | $4.78 | $4.31 | $4.7934 | $4.21 | 117,724 | 17,512 | 14.88% |
| 12-30-2024 | $4.75 | $4.78 | $4.949 | $4.65 | 68,544 | 5,909 | 8.62% |
| 12-27-2024 | $4.92 | $4.81 | $5.08 | $4.5101 | 103,552 | 8,346 | 8.06% |
| 12-26-2024 | $4.86 | $5.11 | $5.1879 | $4.8462 | 161,245 | 40,522 | 25.13% |
| 12-24-2024 | $4.71 | $4.84 | $4.97 | $4.6 | 55,845 | 9,870 | 17.67% |
| 12-23-2024 | $4.46 | $4.71 | $4.71 | $4.29 | 68,486 | 10,460 | 15.27% |
| 12-20-2024 | $4.68 | $4.41 | $4.73 | $4.2259 | 94,876 | 13,129 | 13.84% |
| 12-19-2024 | $4.71 | $4.53 | $4.71 | $4.2 | 134,813 | 32,169 | 23.86% |
| 12-18-2024 | $4.28 | $4.29 | $4.9 | $4.21 | 261,406 | 73,940 | 28.29% |
| 12-17-2024 | $3.84 | $4.2 | $4.78 | $3.84 | 398,318 | 100,747 | 25.29% |
| 12-16-2024 | $4.1 | $3.88 | $4.6077 | $3.65 | 475,841 | 137,561 | 28.91% |
| 12-13-2024 | $5.76 | $4.09 | $5.9492 | $4.08 | 813,232 | 158,181 | 19.45% |
News, Short Squeeze, Breakout and More Instantly...
Aptevo Therapeutics Inc. Company Name:
APVO Stock Symbol:
NASDAQ Market:
Aptevo Therapeutics Inc. Website:
Ad
-
SEATTLE, WASHINGTON / ACCESSWIRE / December 12, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR ® and ADAPTIR-FLEX ® platform te...
-
Two of three patients achieved both complete remission and MRD-negative status High response rates observed in earlier studies continue in ongoing mipletamig trial Cohort 2 enrollment commencing SEATTLE, WA / ACCESSWIRE / December 12, 2024 / Aptevo Therapeutics ("Aptevo") (Nasdaq:...
-
Powered by Aptevo's proprietary ADAPTIR-FLEX ® platform, antibody innovation targeting difficult-to-treat cancers SEATTLE, WA / ACCESSWIRE / December 4, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology the...